Novel therapeutic strategies can be envisioned based on altering the expres
sion level of target genes involved in cellular processes and disease progr
ession; however, our ability to efficiently manipulate gene expression is l
imited. Non-viral-based gene therapy provides a relatively safe approach to
increase or decrease the expression of a specific gene using DNA or antise
nse sequences; however, synthetic systems are required to direct plasmids a
nd oligonucleotides to a specific tissue and to enhance cellular uptake and
intracellular trafficking. Numerous materials are being developed that int
eract with DNA to enhance its properties (e.g. stability, charge density) a
nd thus direct its biodistribution and facilitate cellular interactions. Th
e development of synthetic delivery systems to manipulate gene expression e
fficiently is a powerful tool that will ultimately lead to novel therapeuti
c strategies for the treatment of numerous disorders.